Sign in to view content

Short-term Oral Mifepristone for the Treatment of Central Serous Chorioretinopathy (STOMP-CSC): A Placebo-Controlled Clinical Trial

Roger A. Goldberg, MD, MBA

Video
Published 2018

Related

Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study
David S. Boyer, MD
Updates from the Field
2021
Parameters Affecting Postoperative Success of Surgery for Stage 4a/4b ROP
Sengul Ozdek, MD, FEBO, FASRS
Annual Meeting Talks
2018
A Comparison of the Anatomical Efficacy of Brolucizumab Versus Aflibercept in nAMD Patients: Matched 16-Week Results From the HAWK and HARRIER Studies
Pravin U. Dugel, MD
Annual Meeting Talks
2018

Category: Imaging – Digital-Fluorescein angiography

See more